Full-Time

Inside Sales Representative

Confirmed live in the last 24 hours

Amplity

Amplity

1-10 employees

Database of de-identified medical records

No salary listed

Junior

Nashville, TN, USA + 12 more

More locations: Tampa, FL, USA | Birmingham, AL, USA | Dallas, TX, USA | Philadelphia, PA, USA | Chicago, IL, USA | Charlotte, NC, USA | Little Rock, AR, USA | Kansas City, MO, USA | Columbus, OH, USA | Oklahoma City, OK, USA | Charleston, SC, USA | Baltimore, MD, USA

Category
Inside Sales
Sales & Account Management
Required Skills
Word/Pages/Docs
Salesforce
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree required
  • 1+ years of Pharma Sales experience
  • Experience working in or support of an oncology office and how they operate
  • Ability to understand and explain complex scientific information via telephone
  • Solid presentation skills - Excellent verbal, written and interpersonal communication skills
  • Experience and ability to use PowerPoint, Word, Excel and Salesforce
  • Clear, articulate and grammatically sound speech and professional phone manner
  • Strong focus on providing customers with superior support and service
  • Ability to learn, understand and communicate complex information over the telephone
  • Strong rapport building skills and active listening skills
  • Excellent selling, closing, persuasion and presentation skills
  • Ability to comprehend and communicate complex technical/medical terminology and to maintain the required technical expertise including competitive product knowledge
  • Good organizational and planning skills, strong attention to detail and accuracy
  • Ability to work independently and as a team member
  • Flexibility and ability to handle multiple tasks simultaneously
  • Must be able to successfully complete client training and meet training expectations in order to proceed to servicing client’s customers within the parameters of the program.
Responsibilities
  • Manage daily call responsibilities according to defined expectations, with the purpose of achieving KPIs
  • On behalf of Client, promote Client's product(s) via outbound telephone calls by engaging assigned HCP targets in in-depth program discussions to attain individual, territory and company goals for sales, market share, etc.
  • Respond to inbound calls from HCPs to address their questions regarding product(s), if required by the program.
  • Profile and manage targeted list of HCPs and provide value-added benefits to grow product volume.
  • Maintain call productivity and metrics that are required by program.
  • Prospecting: Successfully qualifying or disqualifying HCPs from a target list
  • Conduct outbound calls to HCPs to appropriately qualify or disqualify HCPs based on prospecting questions
  • Verify and complete required data entry in CRM system, such as details of the target’s responses and any follow-through actions
  • Effectively and persuasively communicate with customers using effective selling, listening and negotiation skills, proper terminology and approved messaging.
  • Maintain thorough knowledge of Client product(s) and program.
  • Listen and respond appropriately to customer needs and questions.
  • Create and maintain a positive impression with client and client’s customers.
  • Fully comply with all laws, regulations and Amplity Policies, Code of Conduct, all privacy and data guidelines and relevant state and federal laws and regulations.
  • Participate in teleconference and live (when required) National, regional and district meetings and training sessions and represent client at National and/or local conventions when applicable.

Amplity focuses on transforming medical records into actionable data for healthcare providers and researchers. The company compiles de-identified medical records into a comprehensive database that can be searched for various elements such as diseases, medications, and devices. This database includes millions of records from diverse specialties across all 50 states, allowing users to gain insights into patient conditions and their interactions with healthcare professionals. Unlike competitors, Amplity offers a unique perspective by providing detailed narrative records, which enhances the understanding of real-world healthcare outcomes. The primary goal of Amplity is to deliver customized access to this valuable data, enabling clients to make informed decisions based on actual patient experiences.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$102.5M

Headquarters

Santa Cruz, California

Founded

2010

Simplify Jobs

Simplify's Take

What believers are saying

  • Amplity's AI-driven platform offers real-time insights for pharmaceutical leaders.
  • The merger with Lynx could expand Amplity's capabilities in medical communications.
  • Amplity's leadership change aims to increase visibility in the biopharmaceutical market.

What critics are saying

  • Rapid AI advancements could outpace Amplity's current healthcare analytics offerings.
  • Integration challenges from the Lynx merger may disrupt service delivery.
  • Data privacy regulations could limit Amplity's access to real-world data insights.

What makes Amplity unique

  • Amplity leverages AI-driven platforms for actionable insights during drug launch windows.
  • Their proprietary database, Amplity Insights, analyzes over 70 million electronic medical records.
  • Amplity's real-world data solutions enhance understanding of clinical decision-making in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Company News

Amplity
May 15th, 2025
Amplity Unveils GLP-1 RAs & Biologic Trends At ISPOR 2025

Amplity unveils GLP-1 RAs & biologic trends at ISPOR 2025.

PR Newswire
Jun 7th, 2024
Amplity Health Study Identifies Major Gaps In Biomarker Testing And Targeted Therapy Use In Non-Small Cell Lung Cancer In The United States

Research presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting shows how the Amplity Health Insights™ Real-World Database enhances understanding of clinical decision-makingLANGHORNE, Pa., June 7, 2024 /PRNewswire/ -- Using point-of-care real-world data to analyze patterns, Amplity Health, a contract sales and medical outsourcing partner, found that biomarker testing for patients with non-small cell lung cancer (NSCLC) in the United States is significantly underutilized. Presented on June 3 at the 2024 ASCO Annual Meeting in Chicago, "Biomarker Testing and Targeted Therapy Use Among Patients With Non-Small Cell Lung Cancer in the United States: An Analysis Using a Physician Notes Real-World Database," highlights critical gaps in testing practices and underscores the need for improved diagnostic strategies.Melanie Jardim, PhD, an Amplity Health executive and principal investigator of the study, shares “Biomarker Testing and Targeted Therapy Use Among Patients with Non-Small Cell Lung Cancer in the United States: An Analysis Using a Physician Notes Real-World Database,” at #ASCO24.By using natural language processing to examine more than 70 million records, this study showed that:A total of 61,018 patients were identified in the Amplity Health Insights ™ Database as having been diagnosed with NSCLC from October 2003 through November 2023™ Database as having been diagnosed with NSCLC from through Of the patients identified in the database as having NSCLC, only 13.4% were recorded as being biomarker testedOf the 6,387 patients with a mutation identified, only approximately 36% received an indicated treatment"Our data further suggest that even when biomarker testing is conducted, and actionable mutations are confirmed, many patients may not be receiving an appropriate targeted therapy," says Melanie Jardim, PhD, an Amplity Health executive and principal investigator of the study."When working with healthcare providers and clients, Amplity's goal is to help remove barriers and address social determinants related to biomarker testing and treatment, ultimately enhancing outcomes across all populations," adds Chris Baker, CEO of Amplity Health.Insights, Amplity's proprietary real-world qualitative database, analyzes over 70 million electronic medical records and effectively uncovers gaps in care. By leveraging data from community settings, combined with ethnicity and SDOH variables, Insights can be used to identify and address social inequities in healthcare. This enables pharmaceutical organizations to better align their strategies to ensure inclusive treatment and access for all patients.About Amplity InsightsAmplity Insights is Amplity Health's proprietary data offering, which provides solutions to clients' most elusive data challenges. By illuminating WHY healthcare practitioners make treatment decisions, our data solutions assist health economics and outcomes research, commercial, clinical, and data analytics teams in biopharma to rapidly move from hypothesis to impact. The mission of Amplity Insights is to maximize the utility of unstructured data by creating easy-to-use, state-of-the-art products and tools to empower leaders to serve patients better.This includes an unparalleled database, the Xplore platform, and the AI-driven search tool, AskX

S&P Global
Feb 21st, 2024
Amplity Health nets $102.5M incremental loan

Earlier this month, Amplity Health announced a merger with medical communications company Lynx.

PR Newswire
Feb 5th, 2024
Amplity Health Announces Leadership Changes

LANGHORNE, Pa., Feb. 5, 2024 /PRNewswire/ -- Amplity Health, a leading global contract medical and commercial organization, announced today that it has appointed Chris Baker to the position of Chief Executive Officer (CEO), effective immediately. Michael A. Griffith, Amplity founder and long-standing CEO, will transition to the role of Chairman of the Board of Directors as part of a deliberate succession plan. In this capacity, he will continue to support Baker and the leadership team, but with a primary focus on building the visibility and awareness of Amplity in the biopharmaceutical market.Chris Baker joins Amplity Health as Chief Executive Officer."More and more, we are seeing a convergence between medical engagement and commercial engagement," says Griffith. "Chris brings significant leadership experience in large pharma commercial operations, contract research, and data to this role

PR Newswire
Feb 5th, 2024
Amplity Health Announces Leadership Changes Usa - English

LANGHORNE, Pa., Feb. 5, 2024 /PRNewswire/ -- Amplity Health, a leading global contract medical and commercial organization, announced today that it has appointed Chris Baker to the position of Chief Executive Officer (CEO), effective immediately. Michael A. Griffith, Amplity founder and long-standing CEO, will transition to the role of Chairman of the Board of Directors as part of a deliberate succession plan. In this capacity, he will continue to support Baker and the leadership team, but with a primary focus on building the visibility and awareness of Amplity in the biopharmaceutical market.Chris Baker joins Amplity Health as Chief Executive Officer."More and more, we are seeing a convergence between medical engagement and commercial engagement," says Griffith. "Chris brings significant leadership experience in large pharma commercial operations, contract research, and data to this role